|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
PHARMACOKINETICS AND PHARMACODYNAMICS |
From the Department of Pharmaceutical Science, Akita University Hospital, Akita, Japan (Dr. Tada, Dr. Suzuki); the Department of Urology, Akita University School of Medicine, Akita, Japan (Dr. Satoh, Dr. Iinuma, Dr. Shimoda, Dr. Kato); and the Department of Pharmaceutical Administration, Hokkaido College of Pharmacy, Hokkaido, Japan (Dr. Murakami, Dr. Hayase).
The circadian variation of clinical pharmacokinetics of tacrolimus was studied using 16 adult renal transplant recipients 1 month after the operation. The recipients were administered tacrolimus twice a day (9 a.m. and 9 p.m.), and whole-blood samples were obtained just prior to and 1, 2, 3, 6, 9, and 12 hours after oral administration. Histological specimens of transplant kidney were collected by an allograft core biopsy on day 28 after the transplantation. There were no circadian changes in the area under the concentration-time curve (AUC0-12) (214 ngh/mL during daytime vs. 223 ngh/mL during nighttime) resulting from morning and night doses. A slight delay in mean residence time (MRT0-12) and time to the peak concentration (tmax) was found after night doses, but there was no statistical significance. Three patients (18.8%) had a clinical acute rejection (AR) episode 4 to 6 weeks after transplantation, and AUC0-12 at nighttime was significantly lower (18.4% on average) in patients with AR in comparison to those without AR. There was no statistical significance in maximum concentration (Cmax) or morning/night trough levels between patients with and without AR. In regard to the correlation between tacrolimus concentrations in each sampling time and AUC0-12, the morning trough concentrations were less predictable for daytime AUC0-12 (r2 = 0.125), but there was a weak correlation to nighttime AUC0-12 (r2 = 0.424). Tacrolimus concentrations at 2, 3, and 6 hours after the morning dose (C2, C3, and C6) had a good correlation against daytime AUC. The results of this study indicate that the variance on the clinical pharmacokinetics of tacrolimus between daytime and nighttime in renal transplant patients is not significant, while the lower nighttime AUC corresponded to the occurrence of AR.
Key Words: Tacrolimus circadian variation bioavailability kidney transplant patient rejection
Address for reprints: Toshio Suzuki, Department of Pharmaceutical Science, Akita University Hospital, Hondo 1-1-1, Akita 010-8543, Japan.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
E. M. Scholten, A. T. Rowshani, S. Cremers, F. J. Bemelman, M. Eikmans, E. van Kan, M. J. Mallat, S. Florquin, J. Surachno, I. J. ten Berge, et al. Untreated Rejection in 6-Month Protocol Biopsies Is Not Associated with Fibrosis in Serial Biopsies or with Loss of Graft Function J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2622 - 2632. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J Curtis, P. Jones, and R. Barbeito Large Within-Day Variation in Cyclosporine Absorption: Circadian Variation or Food Effect? Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 462 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. J. Kuypers, K. Claes, P. Evenepoel, B. Maes, and Y. Vanrenterghem THE RATE OF GASTRIC EMPTYING DETERMINES THE TIMING BUT NOT THE EXTENT OF ORAL TACROLIMUS ABSORPTION: SIMULTANEOUS MEASUREMENT OF DRUG EXPOSURE AND GASTRIC EMPTYING BY CARBON-14-OCTANOIC ACID BREATH TEST IN STABLE RENAL ALLOGRAFT RECIPIENTS Drug Metab. Dispos., December 1, 2004; 32(12): 1421 - 1425. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |